1. Endometrial expression of glycodelin in women with levonorgestrel-releasing subdermal implants 
Erik Mandelin, M.D., Hannu Koistinen, Riitta Koistinen, Ph.D., Johanna Arola, M.D., Biran Affandi, M.D., Markku Seppälä, M.D. 
Fertility and Sterility 
Volume 76, Issue 3, Pages (September 2001)
DOI: /S (01)

2. Figure 1
The relative frequencies of the Gd scores in the four groups of women with implants: 0 = no staining, 1 = 1% to 25%, 2 = 26% to 50%, 3 = 51% to 75%, and 4 = 76% to 100% of the glandular cells were stained.
Mandelin. Subdermal levonorgestrel and glycodelin. Fertil Steril 2001.
Fertility and Sterility  , DOI: ( /S (01) )

3. Figure 2
A representative example demonstrating glycodelin mRNA by in situ hybridization in endometrium taken on day 11 of the cycle. (AS) Antisense strand of glycodelin mRNA showing positive signal in endometrial glands (original magnification ×400). (S) Control experiment on adjacent section using sense strand of glycodelin mRNA (original magnification ×400).
Mandelin. Subdermal levonorgestrel and glycodelin. Fertil Steril 2001.
Fertility and Sterility  , DOI: ( /S (01) )